329 related articles for article (PubMed ID: 32624882)
1. Silica-based organic-inorganic hybrid nanoparticles and nanoconjugates for improved anticancer drug delivery.
Ilhan-Ayisigi E; Yesil-Celiktas O
Eng Life Sci; 2018 Dec; 18(12):882-892. PubMed ID: 32624882
[TBL] [Abstract][Full Text] [Related]
2. Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery.
Yu L; Chen Y; Lin H; Du W; Chen H; Shi J
Biomaterials; 2018 Apr; 161():292-305. PubMed ID: 29427925
[TBL] [Abstract][Full Text] [Related]
3. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.
Chen Y; Chen H; Shi J
Adv Mater; 2013 Jun; 25(23):3144-76. PubMed ID: 23681931
[TBL] [Abstract][Full Text] [Related]
4. Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures.
Chen Y; Chen H; Shi J
Expert Opin Drug Deliv; 2014 Jun; 11(6):917-30. PubMed ID: 24746014
[TBL] [Abstract][Full Text] [Related]
5. Advances in silica based nanoparticles for targeted cancer therapy.
Yang Y; Yu C
Nanomedicine; 2016 Feb; 12(2):317-32. PubMed ID: 26706409
[TBL] [Abstract][Full Text] [Related]
6. Advanced mesoporous silica nanocarriers in cancer theranostics and gene editing applications.
Živojević K; Mladenović M; Djisalov M; Mundzic M; Ruiz-Hernandez E; Gadjanski I; Knežević NŽ
J Control Release; 2021 Sep; 337():193-211. PubMed ID: 34293320
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
Lee JE; Lee N; Kim T; Kim J; Hyeon T
Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
[TBL] [Abstract][Full Text] [Related]
8. Application of Mesoporous Silica Nanoparticles in Cancer Therapy and Delivery of Repurposed Anthelmintics for Cancer Therapy.
Koohi Moftakhari Esfahani M; Alavi SE; Cabot PJ; Islam N; Izake EL
Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 36015204
[TBL] [Abstract][Full Text] [Related]
9. Theranostic applications of mesoporous silica nanoparticles and their organic/inorganic hybrids.
Chen NT; Cheng SH; Souris JS; Chen CT; Mou CY; Lo LW
J Mater Chem B; 2013 Jul; 1(25):3128-3135. PubMed ID: 32260912
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional Mesoporous Silica Nanoparticles for Cancer Therapy and Imaging.
Dilnawaz F
Curr Med Chem; 2019; 26(31):5745-5763. PubMed ID: 29714137
[TBL] [Abstract][Full Text] [Related]
11. Chemistry of Mesoporous Organosilica in Nanotechnology: Molecularly Organic-Inorganic Hybridization into Frameworks.
Chen Y; Shi J
Adv Mater; 2016 May; 28(17):3235-72. PubMed ID: 26936391
[TBL] [Abstract][Full Text] [Related]
12. Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer.
Li T; Shi S; Goel S; Shen X; Xie X; Chen Z; Zhang H; Li S; Qin X; Yang H; Wu C; Liu Y
Acta Biomater; 2019 Apr; 89():1-13. PubMed ID: 30797106
[TBL] [Abstract][Full Text] [Related]
13. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
Li Z; Zhang Y; Feng N
Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
[TBL] [Abstract][Full Text] [Related]
14. Chemoresponsive smart mesoporous silica systems - An emerging paradigm for cancer therapy.
Murugan B; Krishnan UM
Int J Pharm; 2018 Dec; 553(1-2):310-326. PubMed ID: 30316004
[TBL] [Abstract][Full Text] [Related]
15. Bio-Functional Mesoporous Silica Nanoparticles as Nano-Structured Carriers in Cancer Theranostic Review on Recent Advancements.
Gevariya D; Priya L; Mehta S; Patel V; Bhuva D; Panjwani D; Patel S; Ahlawat P; Dharamsi A; Patel A
Curr Drug Targets; 2023; 24(12):934-944. PubMed ID: 37592775
[TBL] [Abstract][Full Text] [Related]
16. Biosafety of mesoporous silica nanoparticles; towards clinical translation.
Lérida-Viso A; Estepa-Fernández A; García-Fernández A; Martí-Centelles V; Martínez-Máñez R
Adv Drug Deliv Rev; 2023 Oct; 201():115049. PubMed ID: 37573951
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Blood Suspensibility and Laser-Activated Tumor-specific Drug Release of Theranostic Mesoporous Silica Nanoparticles by Functionalizing with Erythrocyte Membranes.
Su J; Sun H; Meng Q; Zhang P; Yin Q; Li Y
Theranostics; 2017; 7(3):523-537. PubMed ID: 28255347
[TBL] [Abstract][Full Text] [Related]
18. Hybrid mesoporous silica nanospheres modified by poly (NIPAM-co-AA) for drug delivery.
Zhang K; Zhou D; Wang Z; Zhang Y; He P
Nanotechnology; 2019 Aug; 30(35):355604. PubMed ID: 31071691
[TBL] [Abstract][Full Text] [Related]
19. Our contributions to applications of mesoporous silica nanoparticles.
Vallet-Regí M
Acta Biomater; 2022 Jan; 137():44-52. PubMed ID: 34653693
[TBL] [Abstract][Full Text] [Related]
20. Optically active organic and inorganic nanomaterials for biological imaging applications: A review.
Sowmiya P; Dhas TS; Inbakandan D; Anandakumar N; Nalini S; Suganya KSU; Remya RR; Karthick V; Kumar CMV
Micron; 2023 Sep; 172():103486. PubMed ID: 37262930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
